Evaluation of surrogate endpoints using information-theoretic measure of association based on Havrda and Charvat entropy
Surrogate endpoints have been used to assess the efficacy of a treatment and can potentially reduce the duration and/or number of required patients for clinical trials. Using information theory, Alonso et al. (2007) proposed a unified framework based on Shannon entropy, a new definition of surrogacy...
| Autores: | , , , |
|---|---|
| Formato: | artículo |
| Fecha de publicación: | 2022 |
| País: | España |
| Recursos: | Universidad Complutense de Madrid (UCM) |
| Repositorio: | Docta Complutense |
| Idioma: | inglés |
| OAI Identifier: | oai:docta.ucm.es:20.500.14352/73049 |
| Acesso em linha: | https://hdl.handle.net/20.500.14352/73049 |
| Access Level: | acceso abierto |
| Palavra-chave: | 519.22 Surrogate endpoint Information theory Havrda and Charvat entropy Mutual information Clinical trial design Estadística matemática (Matemáticas) 1209 Estadística |
| id |
ES_2d80b9c2c9cc68adfaa5f7a46e862f9b |
|---|---|
| oai_identifier_str |
oai:docta.ucm.es:20.500.14352/73049 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Evaluation of surrogate endpoints using information-theoretic measure of association based on Havrda and Charvat entropyPardo Llorente, María del CarmenZhao, QianJin, HuaLu, Ying519.22Surrogate endpointInformation theoryHavrda and Charvat entropyMutual informationClinical trial designEstadística matemática (Matemáticas)1209 EstadísticaSurrogate endpoints have been used to assess the efficacy of a treatment and can potentially reduce the duration and/or number of required patients for clinical trials. Using information theory, Alonso et al. (2007) proposed a unified framework based on Shannon entropy, a new definition of surrogacy that departed from the hypothesis testing framework. In this paper, a new family of surrogacy measures under Havrda and Charvat (H-C) entropy is derived which contains Alonso’s definition as a particular case. Furthermore, we extend our approach to a new model based on the information-theoretic measure of association for a longitudinally collected continuous surrogate endpoint for a binary clinical endpoint of a clinical trial using H-C entropy. The new model is illustrated through the analysis of data from a completed clinical trial. It demonstrates advantages of H-C entropy-based surrogacy measures in the evaluation of scheduling longitudinal biomarker visits for a phase 2 randomized controlled clinical trial for treatment of multiple sclerosis.MDPIUniversidad Complutense de Madrid20222022-01-3120222022-01-31journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.14352/73049reponame:Docta Complutenseinstname:Universidad Complutense de Madrid (UCM)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:docta.ucm.es:20.500.14352/730492026-06-02T12:44:21Z |
| dc.title.none.fl_str_mv |
Evaluation of surrogate endpoints using information-theoretic measure of association based on Havrda and Charvat entropy |
| title |
Evaluation of surrogate endpoints using information-theoretic measure of association based on Havrda and Charvat entropy |
| spellingShingle |
Evaluation of surrogate endpoints using information-theoretic measure of association based on Havrda and Charvat entropy Pardo Llorente, María del Carmen 519.22 Surrogate endpoint Information theory Havrda and Charvat entropy Mutual information Clinical trial design Estadística matemática (Matemáticas) 1209 Estadística |
| title_short |
Evaluation of surrogate endpoints using information-theoretic measure of association based on Havrda and Charvat entropy |
| title_full |
Evaluation of surrogate endpoints using information-theoretic measure of association based on Havrda and Charvat entropy |
| title_fullStr |
Evaluation of surrogate endpoints using information-theoretic measure of association based on Havrda and Charvat entropy |
| title_full_unstemmed |
Evaluation of surrogate endpoints using information-theoretic measure of association based on Havrda and Charvat entropy |
| title_sort |
Evaluation of surrogate endpoints using information-theoretic measure of association based on Havrda and Charvat entropy |
| dc.creator.none.fl_str_mv |
Pardo Llorente, María del Carmen Zhao, Qian Jin, Hua Lu, Ying |
| author |
Pardo Llorente, María del Carmen |
| author_facet |
Pardo Llorente, María del Carmen Zhao, Qian Jin, Hua Lu, Ying |
| author_role |
author |
| author2 |
Zhao, Qian Jin, Hua Lu, Ying |
| author2_role |
author author author |
| dc.contributor.none.fl_str_mv |
Universidad Complutense de Madrid |
| dc.subject.none.fl_str_mv |
519.22 Surrogate endpoint Information theory Havrda and Charvat entropy Mutual information Clinical trial design Estadística matemática (Matemáticas) 1209 Estadística |
| topic |
519.22 Surrogate endpoint Information theory Havrda and Charvat entropy Mutual information Clinical trial design Estadística matemática (Matemáticas) 1209 Estadística |
| description |
Surrogate endpoints have been used to assess the efficacy of a treatment and can potentially reduce the duration and/or number of required patients for clinical trials. Using information theory, Alonso et al. (2007) proposed a unified framework based on Shannon entropy, a new definition of surrogacy that departed from the hypothesis testing framework. In this paper, a new family of surrogacy measures under Havrda and Charvat (H-C) entropy is derived which contains Alonso’s definition as a particular case. Furthermore, we extend our approach to a new model based on the information-theoretic measure of association for a longitudinally collected continuous surrogate endpoint for a binary clinical endpoint of a clinical trial using H-C entropy. The new model is illustrated through the analysis of data from a completed clinical trial. It demonstrates advantages of H-C entropy-based surrogacy measures in the evaluation of scheduling longitudinal biomarker visits for a phase 2 randomized controlled clinical trial for treatment of multiple sclerosis. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022 2022-01-31 2022 2022-01-31 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/20.500.14352/73049 |
| url |
https://hdl.handle.net/20.500.14352/73049 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
MDPI |
| publisher.none.fl_str_mv |
MDPI |
| dc.source.none.fl_str_mv |
reponame:Docta Complutense instname:Universidad Complutense de Madrid (UCM) |
| instname_str |
Universidad Complutense de Madrid (UCM) |
| reponame_str |
Docta Complutense |
| collection |
Docta Complutense |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869405325108445184 |
| score |
15.301603 |